228 related articles for article (PubMed ID: 33468584)
1. Murine Intrarectal Instillation of Purified Recombinant
Markham NO; Bloch SC; Shupe JA; Laubacher EN; Thomas AK; Kroh HK; Childress KO; Peritore-Galve FC; Washington MK; Coffey RJ; Lacy DB
Infect Immun; 2021 Mar; 89(4):. PubMed ID: 33468584
[No Abstract] [Full Text] [Related]
2. Intrarectal instillation of Clostridium difficile toxin A triggers colonic inflammation and tissue damage: development of a novel and efficient mouse model of Clostridium difficile toxin exposure.
Hirota SA; Iablokov V; Tulk SE; Schenck LP; Becker H; Nguyen J; Al Bashir S; Dingle TC; Laing A; Liu J; Li Y; Bolstad J; Mulvey GL; Armstrong GD; MacNaughton WK; Muruve DA; MacDonald JA; Beck PL
Infect Immun; 2012 Dec; 80(12):4474-84. PubMed ID: 23045481
[TBL] [Abstract][Full Text] [Related]
3. The role of purified Clostridium difficile glucosylating toxins in disease pathogenesis utilizing a murine cecum injection model.
Zhang Y; Yang Z; Gao S; Hamza T; Yfantis HG; Lipsky M; Feng H
Anaerobe; 2017 Dec; 48():249-256. PubMed ID: 29031928
[TBL] [Abstract][Full Text] [Related]
4. Defining the Roles of TcdA and TcdB in Localized Gastrointestinal Disease, Systemic Organ Damage, and the Host Response during Clostridium difficile Infections.
Carter GP; Chakravorty A; Pham Nguyen TA; Mileto S; Schreiber F; Li L; Howarth P; Clare S; Cunningham B; Sambol SP; Cheknis A; Figueroa I; Johnson S; Gerding D; Rood JI; Dougan G; Lawley TD; Lyras D
mBio; 2015 Jun; 6(3):e00551. PubMed ID: 26037121
[TBL] [Abstract][Full Text] [Related]
5. A novel approach to generate a recombinant toxoid vaccine against Clostridium difficile.
Donald RGK; Flint M; Kalyan N; Johnson E; Witko SE; Kotash C; Zhao P; Megati S; Yurgelonis I; Lee PK; Matsuka YV; Severina E; Deatly A; Sidhu M; Jansen KU; Minton NP; Anderson AS
Microbiology (Reading); 2013 Jul; 159(Pt 7):1254-1266. PubMed ID: 23629868
[TBL] [Abstract][Full Text] [Related]
6. Clostridium difficile toxins A and B decrease intestinal SLC26A3 protein expression.
Coffing H; Priyamvada S; Anbazhagan AN; Salibay C; Engevik M; Versalovic J; Yacyshyn MB; Yacyshyn B; Tyagi S; Saksena S; Gill RK; Alrefai WA; Dudeja PK
Am J Physiol Gastrointest Liver Physiol; 2018 Jul; 315(1):G43-G52. PubMed ID: 29597352
[TBL] [Abstract][Full Text] [Related]
7. Identification of the role of toxin B in the virulence of Clostridioides difficile based on integrated bioinformatics analyses.
Gao Y; Gao W; Cheng J; Ma L; Su J
Int Microbiol; 2020 Nov; 23(4):575-587. PubMed ID: 32388701
[TBL] [Abstract][Full Text] [Related]
8. The xenobiotic sensing pregnane X receptor regulates tissue damage and inflammation triggered by C difficile toxins.
Erickson SL; Alston L; Nieves K; Chang TKH; Mani S; Flannigan KL; Hirota SA
FASEB J; 2020 Feb; 34(2):2198-2212. PubMed ID: 31907988
[TBL] [Abstract][Full Text] [Related]
9. Contribution of adenosine A(2B) receptors in Clostridium difficile intoxication and infection.
Warren CA; Li Y; Calabrese GM; Freire RS; Zaja-Milatovic S; van Opstal E; Figler RA; Linden J; Guerrant RL
Infect Immun; 2012 Dec; 80(12):4463-73. PubMed ID: 23045479
[TBL] [Abstract][Full Text] [Related]
10. Toxin gene analysis of a variant strain of Clostridium difficile that causes human clinical disease.
Sambol SP; Merrigan MM; Lyerly D; Gerding DN; Johnson S
Infect Immun; 2000 Oct; 68(10):5480-7. PubMed ID: 10992443
[TBL] [Abstract][Full Text] [Related]
11. The microbial metabolite urolithin A reduces
Ghosh S; Erickson D; Chua MJ; Collins J; Jala VR
mSystems; 2024 Feb; 9(2):e0125523. PubMed ID: 38193707
[No Abstract] [Full Text] [Related]
12. Study of the frequency of Clostridium difficile tcdA, tcdB, cdtA and cdtB genes in feces of Calves in south west of Iran.
Doosti A; Mokhtari-Farsani A
Ann Clin Microbiol Antimicrob; 2014 Jun; 13():21. PubMed ID: 24903619
[TBL] [Abstract][Full Text] [Related]
13. Emerging toxin A-B+ variant strain of Clostridium difficile responsible for pseudomembranous colitis at a tertiary care hospital in Korea.
Shin BM; Kuak EY; Yoo SJ; Shin WC; Yoo HM
Diagn Microbiol Infect Dis; 2008 Apr; 60(4):333-7. PubMed ID: 18082994
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of the Endosomal Anion/Proton Exchanger ClC-5 Increases Cell Susceptibility toward
Ruhe F; Olling A; Abromeit R; Rataj D; Grieschat M; Zeug A; Gerhard R; Alekov A
Front Cell Infect Microbiol; 2017; 7():67. PubMed ID: 28348980
[TBL] [Abstract][Full Text] [Related]
15. Development of an Effective Nontoxigenic Clostridioides difficile-Based Oral Vaccine against C. difficile Infection.
Wang S; Zhu D; Sun X
Microbiol Spectr; 2022 Jun; 10(3):e0026322. PubMed ID: 35583336
[TBL] [Abstract][Full Text] [Related]
16. Genomic and Phenotypic Characterization of the Nontoxigenic Clostridioides difficile Strain CCUG37785 and Demonstration of Its Therapeutic Potential for the Prevention of C. difficile Infection.
Wang S; Heuler J; Wickramage I; Sun X
Microbiol Spectr; 2022 Apr; 10(2):e0178821. PubMed ID: 35315695
[TBL] [Abstract][Full Text] [Related]
17. Phylogenomics of 8,839 Clostridioides difficile genomes reveals recombination-driven evolution and diversification of toxin A and B.
Mansfield MJ; Tremblay BJ; Zeng J; Wei X; Hodgins H; Worley J; Bry L; Dong M; Doxey AC
PLoS Pathog; 2020 Dec; 16(12):e1009181. PubMed ID: 33370413
[TBL] [Abstract][Full Text] [Related]
18. Comparative genomics of
Janezic S; Dingle K; Alvin J; Accetto T; Didelot X; Crook DW; Lacy DB; Rupnik M
Microb Genom; 2020 Oct; 6(10):. PubMed ID: 33030421
[No Abstract] [Full Text] [Related]
19. Recombinant Clostridium difficile toxin fragments as carrier protein for PSII surface polysaccharide preserve their neutralizing activity.
Romano MR; Leuzzi R; Cappelletti E; Tontini M; Nilo A; Proietti D; Berti F; Costantino P; Adamo R; Scarselli M
Toxins (Basel); 2014 Apr; 6(4):1385-96. PubMed ID: 24759173
[TBL] [Abstract][Full Text] [Related]
20. The enterotoxicity of Clostridium difficile toxins.
Sun X; Savidge T; Feng H
Toxins (Basel); 2010 Jul; 2(7):1848-80. PubMed ID: 22069662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]